HIPINE (SEHK: 02583) has announced its intention to repurchase its own H shares.

The company stated that, within the general mandate granted to the board by shareholders at the Annual General Meeting held on May 11, 2026, it may repurchase H shares on the open market of The Stock Exchange of Hong Kong from time to time, subject to market conditions and the company's actual circumstances.

Under this buyback authorization, the company is permitted to repurchase a maximum number of H shares not exceeding 10% of the total issued H share capital as of the date the mandate was approved, which was May 11, 2026, excluding any treasury shares.

For the purpose of these share repurchases, the company will only use its own legally available internal funds, which may include, but are not limited to, surplus funds and undistributed profits, in accordance with its articles of association and applicable Chinese and other relevant laws.

The total amount of funds the company intends to allocate for this share repurchase program shall not exceed the Hong Kong dollar equivalent of RMB 30 million, based on the exchange rate on the date of the foreign exchange transaction.